From market access to real-world patient access: Closing the gap for biosimilar medicines

#biosimilars #marketaccess #pharmaceuticalspending #healthcaresystemsustainability #regulatoryapproval #reimbursement #patientaccess #regulatoryapprovals #comparativeefficacytrials #MHRA #intellectualproperty #regulatorypathways #valuebasedhealthcare
pharmaphorum.com/deep-dive/ma...